Viewing Study NCT06614673



Ignite Creation Date: 2024-10-26 @ 3:41 PM
Last Modification Date: 2024-10-26 @ 3:41 PM
Study NCT ID: NCT06614673
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-09-24

Brief Title: Cancer Literacy As an Essential Factor for Lifestyle Behavior Changes an Observational and Interventional Study
Sponsor: None
Organization: None

Study Overview

Official Title: Cancer Literacy As an Essential FactoR for Lifestyle BehaviOr Changes an Observational and Interventional Study
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CLARO
Brief Summary: The CLARO study aims to examine the most effective way to design information materials that can strengthen optimistic beliefs about cancer prevention and improve cancer literacy indirectly Around 5800 participants from the Stuttgart region in Germany will be contacted by postal mail and invited to take part in an online survey using the LimeSurvey-System Four different types of information materials tested in a pilot study 2x2-design text or animation-based narrative or non-narrative will be included in the survey Participants will be randomly assigned to one of the four interventions or to a control group that will not receive any intervention the control group will have access to all information materials after having completed the whole questionnaire As an incentive participants will receive 10 via bank transfer upon completing the survey
Detailed Description: The online survey can be accessed through a unique link or QR code and is compatible with various electronic devices such as PCs tablets and smartphones Reminders will be sent after one month and two months Participants can also request a paper questionnaire if needed We will make an effort to contact more people from districts with lower socioeconomic status Furthermore the study cover letter will disclose that all study participants will receive ten euros if they provide their bank details after completion of the study questionnaires Participants will be redirected via a link to another LimeSurvey for this purpose

The online questionnaire will be divided into two parts The first part which will assess sociodemographic information questions on cancer literacy and more will take about 10 minutes Subsequently participants will be randomly assigned to one of the four intervention groups or to a control group Reading or viewing the information materials will take about 5 minutes In the second part of the questionnaire participants will evaluate the information materials assess intentions for health behaviors and have access to further information materials approximately 5 minutes The control group will have access to all information materials after having completed the whole questionnaire

The primary aims of the observational part of the study are first to assess levels of cancer literacy in a representative German population including all four cancer literacy domains ie access understand appraise apply Second this study part aims to identify sociodemographic groups eg defined by age sex sociodemographic background educational level showing significantly lower levels of cancer literacy As a secondary aim the observational part of the study determines levels of cancer prevention behaviors in Germany ie smoking status diet alcohol consumption and physical activity

The primary aim of the interventional part of the study is to assess the effects of different health communication strategies ie text or animation in non-narrative or narrative style on the primary outcome of cancer prevention beliefs The secondary aim is to examine health communication strategies in their effect on secondary outcomes ie intention for cancer prevention behaviors

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None